Endovascular Repair of a Pseudoaneurysm After Multiple Open Repairs of Aortic Coarctation

Successful surgical repair of aortic coarctation during childhood may have major late complications such as pseudoaneurysm formation. If left untreated, pseudoaneuryms put patients at risk for morbidity and death; if treated surgically, they are associated with complications. Endovascular aortic rep...

Full description

Saved in:
Bibliographic Details
Published in:Texas Heart Institute journal Vol. 47; no. 2; pp. 149 - 151
Main Authors: Alnasser, Saleh A, Vunnamadala, Kalyan C, Preventza, Ourania A, Coselli, Joseph S, de la Cruz, Kim I
Format: Journal Article
Language:English
Published: United States Texas Heart® Institute, Houston 01-04-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Successful surgical repair of aortic coarctation during childhood may have major late complications such as pseudoaneurysm formation. If left untreated, pseudoaneuryms put patients at risk for morbidity and death; if treated surgically, they are associated with complications. Endovascular aortic repair, an established safe alternative to open surgical repair, is associated with encouraging outcomes and fewer complications, and it is especially feasible for patients who have undergone multiple aortic surgeries. We report the case of a 41-year-old man who underwent endovascular repair of a pseudoaneurysm after previous surgical corrections of an aortic coarctation at 6 and 14 years of age. The pseudoaneurysm, involving the distal portion of an ascending-to-descending aortic 20-mm Dacron bypass graft, was successfully excluded with a thoracic stent-graft and sealed off with vascular plugs to prevent both blood flow into the pseudoaneurysm and type II endoleak.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Dr. Coselli is principal investigator for clinical trials conducted by Medtronic, Inc.; W.L. Gore & Associates; and Cook Medical, Inc.; spoke at a Medtronic-sponsored meeting; serves on a W.L. Gore advisory board; and consults for and receives royalties from Vascutek Ltd., a Terumo company. Dr. Preventza consults for Medtronic and W.L. Gore and had travel paid by Cook Medical.
ISSN:0730-2347
1526-6702
DOI:10.14503/THIJ-17-6423